Central Kentucky Research Associates, LLC

Lexington, Kentucky 40509

0 studies enrolling now · 5 studies all time

What they study most

Atopic Dermatitis, Clostridium Difficile Infection, Smoking Cessation

Studies at this site

• Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis — Stopped early
• Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) — Completed
• Clostridium Difficile Vaccine Efficacy Trial — Completed
• Trial of Cytisine in Adult Smokers — Completed
• Safety and Efficacy Study of the NRT CQSS2 System for Smoking Cessation in Treatment-Seeking Subjects — Completed